Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

16.650
+0.0700.42%
Volume:4.04M
Turnover:67.05M
Market Cap:51.96B
PE:6.23
High:16.670
Open:16.580
Low:16.460
Close:16.580
52wk High:21.258
52wk Low:15.187
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:0.95
T/O Rate:0.30%
Dividend:0.81
Dividend Rate:4.84%
EPS(LYR):2.672
ROE:8.11%
ROA:2.63%
PB:0.52
PE(LYR):6.23
PS:0.08

Loading ...

Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares

Stock News
·
Mar 27

Sinopharm Group Stock Falls 3.6% in Hong Kong

Dow Jones
·
Mar 24

UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year

Stock News
·
Mar 24

SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price

Stock News
·
Mar 24

Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million

Reuters
·
Mar 23

SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners

Stock News
·
Mar 23

BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN

Reuters
·
Mar 23

Sinopharm Group proposes final dividend of RMB 0.69 per share

Reuters
·
Mar 23

Sinopharm Group - FY Profit Attributable RMB7.16 Bln

THOMSON REUTERS
·
Mar 23

Sinopharm Group - Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed

THOMSON REUTERS
·
Mar 23

Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention

Simply Wall St.
·
Mar 20

SINOPHARM Subsidiary Reports Annual Operating Profit of RMB 1.25 Billion, Up 2.38%

Stock News
·
Mar 19

Sinopharm subsidiary CNMDC posts RMB 74.89 billion 2025 revenue and RMB 506.76 million comprehensive income attributable to parent owners

Reuters
·
Mar 19

OSR subsidiary Woori IO signs NDA with Sinopharm to explore China opportunities

Reuters
·
Mar 19

Sinopharm Group (01099.HK): Subsidiary Sinopharm Accord Posts 76.8% Surge in 2025 Net Profit Despite 1.29% Dip in Revenue

Bulletin Express
·
Mar 18

Sinopharm Accord net profit rises 76.8% to RMB1.14 billion in 2025

Reuters
·
Mar 18

Sinopharm Group FY Revenue RMB 73,416 Million

THOMSON REUTERS
·
Mar 18

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
Mar 17

Sinopharm Group Stock Rallies 1.4% in Hong Kong

Dow Jones
·
Mar 16

Sinopharm Group Stock Rises 1.3% in Hong Kong

Dow Jones
·
Mar 12